Prediction of Vagal Nerve Stimulation Efficacy in Drug-Resistant Epilepsy (PRECISE): Prospective Study for Pre-implantation Prediction/Study Design

Irena Dolezalova, Eva Koritakova, Lenka Souckova, Jan Chrastina, Jan Chladek, Radka Stepanova, Milan Brazdil, Irena Dolezalova, Eva Koritakova, Lenka Souckova, Jan Chrastina, Jan Chladek, Radka Stepanova, Milan Brazdil

Abstract

Background: Vagal nerve stimulation (VNS) can be indicated in patients with drug-resistant epilepsy, who are not eligible for resective epilepsy surgery. In VNS therapy, the responder rate (i.e., percentage of subjects experiencing ≥50% seizure reduction) is ~50%. At the moment, there is no widely-accepted possibility to predict VNS efficacy in a particular patient based on pre-implantation data, which can lead to unnecessary surgery and improper allocation of financial resources. The principal aim of PRediction of vagal nerve stimulation EfficaCy In drug-reSistant Epilepsy (PRECISE) study is to verify the predictability of VNS efficacy by analysis of pre-implantation routine electroencephalogram (EEG).

Methods: PRECISE is designed as a prospective multicentric study in which patients indicated to VNS therapy will be recruited. Patients will be classified as predicted responders vs. predicted non-responders using pre-implantation EEG analyses. After the first and second year of the study, the real-life outcome (responder vs. non-responder) will be determined. The real-life outcome and predicted outcome will be compared in terms of accuracy, specificity, and sensitivity. In the meantime, the patients will be managed according to the best clinical practice to obtain the best therapeutic response. The primary endpoint will be the accuracy of the statistical model for prediction of response to VNS therapy in terms of responders and non-responders. The secondary endpoint will be the quantification of differences in EEG power spectra (Relative Mean Power, %) between real-life responders and real-life non-responders to VNS therapy in drug-resistant epilepsy and the sensitivity and specificity of the model.

Discussion: PRECISE relies on the results of our previous work, through which we developed a statistical classifier for VNS response (responders vs. non-responders) based on differences in EEG power spectra dynamics (Pre-X-Stim).

Trial registration: www.ClinicalTrials.gov, identifier: NCT04935567.

Keywords: drug-resistant epilepsy; efficacy prediction; statistical model; study design; vagal nerve stimulation.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Dolezalova, Koritakova, Souckova, Chrastina, Chladek, Stepanova and Brazdil.

References

    1. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. (2000) 342:314–9. 10.1056/NEJM200002033420503
    1. Kuba R, Brazdil M, Kalina M, Prochazka T, Hovorka J, Nezadal T. Vagus nerve stimulation: longitudinal follow-up of patients treated for 5 years. Seizure. (2009) 18:269–74. 10.1016/j.seizure.2008.10.012
    1. Englot DJ, Chang EF, Auguste KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg. (2011) 115:1248–55. 10.3171/2011.7.JNS11977
    1. Englot DJ, Rolston JD, Wang DD, Hassnain KH, Gordon CM, Chang EF. Efficacy of vagus nerve stimulation in posttraumatic versus nontraumatic epilepsy. J Neurosurg. (2012) 117:970–7. 10.3171/2012.8.JNS122
    1. Englot DJ, Rolston JD, Wright CW, Hassnain KH, Chang EF. Rates and predictors of seizure freedom with vagus nerve stimulation for intractable epilepsy. Neurosurgery. (2016) 79:345–53. 10.1227/NEU.0000000000001165
    1. Brázdil M, DoleŽalová I, Koritáková E, Chládek J, Roman R, Pail M. EEG reactivity predicts individual efficacy of vagal nerve stimulation in intractable epileptics. Front Neurol. (2019) 10:392. 10.3389/fneur.2019.00392
    1. Koritakova E, Dolezalova I, Chladek J, Jurkova T, Chrastina J, Plesinger F. A novel statistical model for predicting the efficacy of vagal nerve stimulation in patients with epilepsy (Pre-X-Stim) is applicable to different EEG systems. Front Neurosci. (2021) 15:635787. 10.3389/fnins.2021.635787
    1. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Hauser WA, Mathern G. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. (2010) 51:1069–77. 10.1111/j.1528-1167.2009.02397.x
    1. Jobst BC, Cascino GD. Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA. (2015) 313:285–93. 10.1001/jama.2014.17426
    1. Giordano F, Zicca A, Barba C, Guerrini R, Genitori L. Vagus nerve stimulation: surgical technique of implantation and revision and related morbidity. Epilepsia. (2017) 58(Suppl. 1):85–90. 10.1111/epi.13678
    1. Chrastina J, Novak Z, Zeman T, Kocvarova J, Pail M, Dolezalova I. Single-center long-term results of vagus nerve stimulation for epilepsy: a 10-17 year follow-up study. Seizure. (2018) 59:41–7. 10.1016/j.seizure.2018.04.022
    1. Ryvlin P, Gilliam FG, Nguyen DK, Colicchio G, Iudice A, Tinuper P. The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial. Epilepsia. (2014) 55:893–900. 10.1111/epi.12611
    1. Beckstead RM, Morse JR, Norgren R. The nucleus of the solitary tract in the monkey: projections to the thalamus and brain stem nuclei. J Comp Neurol. (1980) 190:259–82. 10.1002/cne.901900205
    1. Rutecki P. Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia. (1990) 31(Suppl. 2):S1–6. 10.1111/j.1528-1157.1990.tb05843.x
    1. Vonck K, De Herdt V, Bosman T, Dedeurwaerdere S, Van Laere K, Boon P, et al. . Thalamic and limbic involvement in the mechanism of action of vagus nerve stimulation, a SPECT study. Seizure. (2008) 17:699–706. 10.1016/j.seizure.2008.05.001
    1. Hachem LD, Wong SM, Ibrahim GM. The vagus afferent network: emerging role in translational connectomics. Neurosurgical Focus. (2018) 45:E2. 10.3171/2018.6.FOCUS18216
    1. Ibrahim GM, Sharma P, Hyslop A, Guillen MR, Morgan BR, Wong S. Presurgical thalamocortical connectivity is associated with response to vagus nerve stimulation in children with intractable epilepsy. Neuroimage Clin. (2017) 16:634–42. 10.1016/j.nicl.2017.09.015
    1. Babajani-Feremi A, Noorizadeh N, Mudigoudar B, Wheless JW. Predicting seizure outcome of vagus nerve stimulation using MEG-based network topology. Neuroimage Clinl. (2018) 19:990–9. 10.1016/j.nicl.2018.06.017
    1. Mithani K, Mikhail M, Morgan BR, Wong S, Weil AG, Deschenes S. Connectomic profiling identifies responders to vagus nerve stimulation. Ann Neurol. (2019) 86:743–53. 10.1002/ana.25574

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe